Background: End-of-life medical expenditures exceed costs of care during other years, vary across regions, and are likely to be unsustainable. Identifying determinants of expenditure variation may reveal opportunities for reducing costs.
M
edical expenditures in the final months of life exceed costs of care during other years (1-3) and vary across demographic groups (2, 4 -8) and geographic regions (9 -11) . Previous research suggests that high-cost, high-intensity treatment in the last year of life may not be associated with greater quality, improvements in outcomes, or increased satisfaction (10 -15) . Local medical resources (for example, hospital bed supply and medical specialists per capita) influence treatment intensity (16 -20) , as do systemic factors specific to individual hospital-physician networks (21) (22) (23) .
Studies of medical expenses at the end of life have typically focused on patients with a single diagnosis or characteristic and have not simultaneously considered regional variation (1, 5, 6, 24 -26) . Other studies using administrative data sets with limited information on individual patient characteristics have relied on census-level proxies for sociodemographic characteristics (19) and have not examined contributions of other individual patient characteristics (for example, functional status) (9) . Identification of patient-level determinants of care intensity may reveal opportunities for patient-centered interventions to reduce medical costs and inappropriate variation.
We hypothesized that race or ethnicity, financial net worth, social support, and functional status are independently associated with treatment intensity after regional characteristics are controlled for, and that these individual characteristics account for a substantial proportion of the previously described variation in end-of-life medical expenses. We sought to identify patient-level characteristics that predict Medicare expenditures, independent of geographic region and local medical resources, in the last 6 months of life among decedents from the Health and Retirement Study (HRS) (27) . We also quantified the relative contributions of patient-level and regional characteristics to expenditures.
METHODS

Conceptual Framework
The conceptual model for this study, detailed elsewhere (28) , postulates that end-of-life treatment intensity is influenced by both regional and patient-based determinants. Regional determinants of treatment intensity include regional supply of medical resources, local or institutional patterns of care, and physician practice patterns. Patient-based determinants include such factors as medical need, financial access to care, personal treatment preferences, and communication of preferences, which are in turn influenced by specific quantifiable patient characteristics (demographic, socioeconomic, medical, functional, and psychosocial). Finally, family members frequently act as caregivers and surrogate decision makers and thus may also affect end-of-life treatment intensity.
Data Sources
HRS Data
We sampled decedents from the HRS, an ongoing longitudinal study funded by the National Institute on Aging that includes a nationally representative cohort of adults 50 years or older. The original HRS sample was assembled in 1992, and more than 30 000 persons have been enrolled. A complete description of the HRS, including recruitment and enrollment procedures, is available at http://hrsonline.isr.umich.edu. Serial "core" interviews are conducted every 2 years, and response rates for each interview wave have exceeded 86%. During each interview cycle, the HRS identifies participants who died since the last core interview, and "exit" interviews are conducted with proxies knowledgeable about the deceased participant (response rate, 93%). Together, the core and exit interviews include the participant's demographic, economic, social, and functional characteristics. The HRS obtains dates of death from the National Death Index. Core interviews are completed a mean of 15.7 months (SD, 12.6) before death, and exit interviews are completed a mean of 12.4 months (SD. 3.9) after death.
Medicare Data
More than 80% of HRS participants provided authorization to merge their HRS data with Medicare claims (27). Medicare claims data are used to identify each participant's chronic medical conditions and total expenditures during the last 6 months of life (29) .
Regional Data
Using the decedent's zip code, we linked each participant to a hospital referral region, as defined by The Dartmouth Atlas of Health Care (9) . The Dartmouth Atlas database provides several measures of regional health care supply at the hospital referral region level, including number of hospital beds, physicians, primary care physicians, and specialist physicians (9) . The Atlas has also calculated an End-of-Life Expenditure Index (EOL-EI), a measure of physician practice patterns based on utilization patterns among Medicare beneficiaries in the last 6 months of life (10), for each hospital referral region. Using the 2005 American Hospital Association database, we calculated the proportion of hospitals designated as major teaching hospitals (members of the Association of American Medical College's Council of Teaching Hospitals and Health Systems) and the proportion reporting palliative care services within each hospital referral region.
Sample
We included HRS decedents aged 65. To ensure complete claims data, we excluded those who were enrolled in Medicare managed care at any point during the last 6 months of life (n ϭ 445) or were not continuously enrolled in Medicare Parts A and B (n ϭ 48). Excluded persons did not significantly differ from the final study sample (n ϭ 2394) in terms of age, sex, race, education, or net worth.
Outcome Variable
The primary outcome was total Medicare expenditures in the last 6 months of life. This measure includes all Medicare claims for inpatient, outpatient, skilled nursing facility, hospice and home care, and durable medical equipment. Claims that spanned the 180th day before death were prorated to estimate only that proportion of the expenditures within the last 6 months. We adjusted expenditures for inflation (2006 U.S. dollars) on the basis of the medical services component of the consumer price index and for geographic differences in Medicare price levels by
Context
Medical expenses in the final months of life are high and vary according to geographic region and patient characteristics. Understanding patient-level determinants of care intensity may allow for interventions aimed at reducing inappropriate variations in care and costs.
Contribution
This analysis of patients during the last 6 months of life evaluated clinical variables, costs, and regional health care factors and found that a substantial portion of previously described variations in health care expenditures were due to patient-level characteristics. Higher expenditures were associated with decline in functional status, race and ethnicity, certain chronic conditions, and lack of nearby family support.
Implication
Targeting particular patient groups may help reduce inappropriate variations in care and reduce costs.
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Independent Variables
We selected patient-level and regional variables that could serve as empirical measures of each construct in the conceptual model. Patient-level variables collected from the core interview included age, race and ethnicity, sex, education level, net worth, religiosity, urban residence, selfrated health, and having relatives live nearby (a proxy for social support). Proxy-reported variables from the exit interview included marital status, residential status (living in a nursing home, living alone, or living with others), nonMedicare insurance coverage (Medicaid, Veterans Administration, or MediGap), and completion of an advance directive or discussion of end-of-life care preferences. Functional status, based on the person's need for assistance with 6 basic activities of daily living (ADL), was determined at the time of the core interview and again by proxy report of status during the 3 months before death. Using both time points, we constructed categorical measures of functional stability or decline over time. Less than 1% of participants experienced an improvement in functional status (transitioning from 1 to 3 ADL deficiencies to no deficiencies), and these participants were combined with those who were independent at both time points. Chronic medical conditions were identified by the International Classification of Diseases, Ninth Revision, Clinical Modification criteria (30), using Medicare claims from 6 to 18 months preceding death. This time frame was chosen to identify chronic conditions relevant to the participant's ongoing medical care while excluding new conditions identified in the last 6 months because of potential reverse causality with the expenditure outcome. We conducted sensitivity analyses of all final models to measure the effect of using different date cut points (0 to 12 months before death) on our findings and to test the effect of substituting self-reported chronic conditions for the claims-based designations (29) ; neither the magnitude of any of the effect sizes nor statistical significance changed. Regional variables drawn from the Dartmouth Atlas included EOL-EI, number of hospital beds per 10 000 residents, and number of primary care and specialist physicians per 100 000 residents. Because the latter 2 variables were highly collinear (0.80; P Ͻ 0.01), they could not be included simultaneously in regression models. Regional variables drawn from the American Hospital Association database included the proportion of regional hospitals that are teaching hospitals and that have palliative care services.
Statistical Analysis
We evaluated summary statistics and frequency distributions for all variables. To investigate the relationships between patient-level and regional characteristics and the primary outcome-Medicare expenditures in the last 6 months of life-we estimated a series of 2-level models with a random intercept at the region (hospital referral region) level. We compared 3 multivariable models and an unconditional model without covariates to evaluate relative contributions of each set of covariates toward the variation in the outcome (31) . The first multivariable model included only patient characteristics and the random intercept for region. The second multivariable model included only regional characteristics. The third model included patient-level variables in the first level and regional variables in the second level to account for clustering of patients within regions. The proportion of variance explained by each model was calculated as the total variance from the unconditional model minus the total variance from the conditional model, divided by the total variance from the unconditional model (31) .
Because of the skewed distribution of the outcome, we used a gamma distribution with a log link for the regression models. Gamma coefficients generated by the regression models were exponentiated to retransform them into rate ratio (RR) estimates.
We explored the possibility that functional status could mediate the relationship between chronic conditions and expenditures by comparing the final model with one without functional status variables. To examine whether our findings are consistent among those with supplemental insurance, we also reconstructed the models among the subgroup with supplemental Medigap insurance. We used multiple imputations (5 cycles) to account for missing data (32) . Missing data accounted for 3.5% of data values and were most frequent among race (2%), education (7%), and net worth (14%). We used SAS, version 9.2 (SAS Institute, Cary, North Carolina), for all statistical analyses.
The Mount Sinai School of Medicine institutional review board, the HRS Data Confidentiality Committee, and the Centers for Medicare & Medicaid Services Privacy Board approved the study.
Role of the Funding Source
The Brookdale Foundation provided support for this study. It had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript. . When functional characteristics were removed from the model, relationships between cancer and heart failure and higher expenditures became evident but did not reach statistical significance (data not shown). Advance care planning (written advance directives or any discussion of end-of-life treatment preferences) was not associated with expenditures, nor was sex, marital status, education, net worth, nursing home residence, or religiosity. Person-level characteristics included in model 1 account for 10% of the expenditure variation in the last 6 months of life.
RESULTS
Model 2 ( Table 2) evaluates the association between regional characteristics and resources on Medicare expenditures. The EOL-EI, defined as quintiles of regional practice patterns for end-of-life treatment intensity (10) , is strongly associated with Medicare expenditures (RR, 1.10 [CI, 1.06 to 1.14]). For example, a person in a region with an EOL-EI of 2 incurs 10% more Medicare expenditures in the last 6 months of life than a person in a region with an EOL-EI of 1, holding all other characteristics equal. An increasing number of hospital beds per capita is associated with higher expenditures at the end of life (RR, 1.01 [CI, 1.00 to 1.02]). For example, each additional bed per 10 000 residents would increase Medicare expenditures in the last 6 months of life by 1% if all other factors were held equal. The regional characteristics included in model 2 account for 5% of the total variation in Medicare expenditures in the last 6 months of life.
Model 3 ( Table 2 ) evaluates the simultaneous association between patient-level and regional characteristics and Medicare expenditures in a 2-level multivariable model. All patient characteristics associated with expenditures in model 1 maintain their associations and effect sizes after the addition of regional-level characteristics. Similarly, EOL-EI and number of hospital beds, the regional variables found to be associated with greater expenditures in Original Research Determinants of Treatment Intensity model 2, maintained a similar effect size after adjustment for patient characteristics. The independent variables in model 3 explain 15% of the variation in endof-life expenditures. When we reconstructed all 3 models using only persons who have Medigap insurance (n ϭ 1439), we found similar patterns of associations, with patient characteristics explaining 6% of the variation, regional characteristics 4%, and the full 2-level model 10% (data not shown).
DISCUSSION
To our knowledge, our study is the first to combine detailed longitudinal patient-level data, individual Medi- 
Region characteristic
Hospital beds per 10 000 residents 1.01 (1.00-1.02) 1.01 (1.00-1.02) Specialists per 100 000 residents 1.00 (1.00-1.00) 1.00 (1.00-1.00) Proportion of regional hospitals that are teaching hospitals 1.00 (0.99-1.01) 1.00 (0.99-1.01) Proportion of regional hospitals reporting palliative care services 1.00 (1.00-1.00) 1.00 (1.00-1.00) End-of-Life Expenditure Index 1.10 (1.06-1.14) 1.09 (1.05-1.13)
ADL ϭ activities of daily living. * Functional stability or decline over time measured by comparing functional status at last core interview, with proxy report of status during the 3 mo before death.
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Determinants of Treatment Intensity www.annals.orgcare claims, and regional characteristics to examine regional and patient-level correlates of expenditures simultaneously. Our analyses demonstrate that a substantial portion of previously described variations in health care expenditures are due to patient-level characteristics, and those factors remain highly significant after accounting for regional characteristics. These results are consistent with recent work examining sources of geographic variation in Medicare spending (33) and extend those analyses by examining more detailed health, functional, and social characteristics. The association between regional characteristics and expenditures also remains significant when adjusting for patientlevel characteristics. Of note, a large proportion of observed variation remains unexplained after both patient and regional characteristics were controlled for. Functional impairment and decline are powerful, independent predictors of Medicare expenditures at the end of life. Previous work has demonstrated the high morbidity and mortality associated with functional impairment, particularly among hospitalized older adults (34 -37) , and the general lack of disease-specific patterns of functional decline (38) . This study provides additional evidence linking functional impairment and total Medicare expenditures. Exploratory analyses suggest that for some conditions, including cancer and heart failure, functional status may partially mediate the relationship with expenditures. Quality and coordination of care for patients with functional impairment and several chronic medical conditions are often poor (39 -42) . On the basis of these analyses, we hypothesize that health care reforms may have a greater effect on improving care and reducing costs if they prioritize patient-centered, rather than single disease-oriented, models of care. These efforts should include high-quality primary care and well-coordinated care for these complicated and functionally impaired patients.
The substantial association between having a nearby relative and lower Medicare costs is noteworthy and may indicate that relatives can act as caregivers or advocates to help patients avoid undesired hospitalizations and interventions. The availability of a caregiver may allow patients to choose a preferred treatment plan (for example, care at home instead of in the hospital) that incurs fewer Medicare expenses. However, such a treatment plan may lead to shifting of expenses from Medicare to the patient or caregiver in the form of lost time from work or paying for hired caregivers. Further investigation of this finding is warranted, given the potential for important policy implications.
We observed significantly greater expenditures among black persons and Hispanic persons than non-Hispanic white persons. This finding is consistent with other studies (6, 25) ; further research is needed to determine the extent to which this greater treatment intensity is due to patient preferences, differential access to medical services, disparities in preventive care and provider continuity, or other factors (8, (43) (44) (45) . Of note, we found no association between Medicare expenditures and advance directives or discussion of end-of-life care preferences. These data do not provide sufficient detail to evaluate the possibility that some patients expressed a care preference for intensive treatment-one possible explanation for this finding. However, for the subset of patients with a living will (n ϭ 1042), 92% stated a preference for comfort-focused care. These data suggest that patient preferences, as documented in living wills, are poorly correlated with treatment delivered, which is consistent with other published data (16, 46 -48) . In addition, based on previous work (49) we expected religiosity to be correlated with increased expenditures, yet we found no association.
This study has limitations. Our analyses examined only decedents and did not account for survivors of intensive medical care. However, we intend this study to build on the substantial body of previous work that has focused on decedents (11, 23) . Future research is needed to prospectively apply this conceptual framework to the full spectrum of adults with serious and life-threatening illness. Furthermore, several pieces of data were collected retrospectively from proxy informants and subject to recall bias. We identified chronic conditions through claims rather than by patient report, which may identify only persons with very severe disease and overestimate the relationship with expenditures, as we hypothesize was the case with arthritis. Using claims to identify chronic conditions may also minimize regional effects due to varying diagnostic practices (50). Our data also contained a limited set of predictors and do not contain adequate proxy measures of physician practice patterns, specific patient preferences for end-of-life care, or family preferences about care. We were also not able to control for the availability of palliative care community services, including hospice within regions. Finally, in order to ensure comparability across respondents with differing supplementary insurance and to facilitate comparisons with other studies, these analyses only consider Medicare expenditures and include neither costs covered by other insurance sources (for example, Medicaid or Veterans Administration) nor out-of-pocket expenditures.
In conclusion, patient-level characteristics, including functional decline, chronic disease, caregiver support, and race and ethnicity, are significant determinants of Medicare expenditures at the end of life, independent of regional characteristics. Although regional variation must be addressed, our findings suggest that a larger proportion of overall variation is driven by differences among persons, and most of the observed variation remains unexplained. Furthermore, this study indicates that specific characteristics place persons at a greater risk for high-cost, highintensity treatment: functional decline, chronic medical conditions, and not having family nearby. This suggests opportunities for interventions that identify and target patients at increased risk for high-intensity treatment in order to determine when and whether high-cost life-sustaining treatment is consistent with patient preferences or indicaOriginal Research Determinants of Treatment Intensity tive of inappropriate, poor-quality medical care. This knowledge will be critical for the development of policies and guidelines to decrease population-level health disparities, excessive expenditures, and patient suffering.
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